Literature DB >> 17643770

Primary immunization of premature infants with gestational age <35 weeks: cardiorespiratory complications and C-reactive protein responses associated with administration of single and multiple separate vaccines simultaneously.

Massroor Pourcyrous1, Sheldon B Korones, Kristopher L Arheart, Henrietta S Bada.   

Abstract

OBJECTIVE: To determine the incidence of cardiorespiratory events and abnormal C-reactive protein (CRP) level associated with administration of a single vaccine or multiple separate vaccines simultaneously. STUDY
DESIGN: Prospective observational study on 239 preterm infants at > or =2 months of age in the neonatal intensive care unit (NICU). Each infant received either a single vaccine or multiple vaccines on one day. CRP levels and cardiorespiratory manifestations were monitored for 3 days following immunization.
RESULTS: Abnormal elevation of CRP level occurred in 85% of infants administered multiple vaccines and up to 70% of those given a single vaccine. Overall, 16% of infants had vaccine-associated cardiorespiratory events within 48 hours postimmunization. In logistic regression analysis, abnormal CRP values were associated with multiple vaccines (OR, 15.77; 95% CI 5.10-48.77) and severe intraventricular hemorrhage (IVH) (OR, 2.28; 95% CI 1.02-5.13). Cardiorespiratory events were associated marginally with receipt of multiple injections (OR, 3.62; 95% CI 0.99-13.25) and significantly with gastroesophageal reflux (GER) (OR, 4.76; 95% CI 1.22-18.52).
CONCLUSION: CRP level is expected to be elevated in the 48 hours following immunization. In a minority of infants immunized, cardiorespiratory events were associated with presumed need for intervention. Underlying medical conditions and possibly multiple injections are associated with cardiorespiratory events. Precautionary monitoring following immunizations is warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643770     DOI: 10.1016/j.jpeds.2007.02.059

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Inflammatory responses to hepatitis B virus vaccine in healthy term infants.

Authors:  Istemi Han Celik; Gamze Demirel; Fuat Emre Canpolat; Omer Erdeve; Ugur Dilmen
Journal:  Eur J Pediatr       Date:  2013-01-29       Impact factor: 3.183

2.  C-reactive protein levels following hepatitis B vaccine in healthy newborns.

Authors:  F Dapaah-Siakwan; A Gunasekaran; D L Schutzman
Journal:  J Perinatol       Date:  2015-11-12       Impact factor: 2.521

Review 3.  Frequently asked questions on seven rare adverse events following immunization.

Authors:  G L D'alò; E Zorzoli; A Capanna; G Gervasi; E Terracciano; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2017-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.